Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:ECORNASDAQ:PDEXNASDAQ:PROF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$3.64+12.7%$3.96$2.34▼$8.79$131.27MN/A204,872 shs191,576 shsECORelectroCore$4.97-1.0%$6.21$4.47▼$19.49$36.88M0.9292,618 shs77,317 shsPDEXPro-Dex$46.24+1.4%$53.10$16.84▼$70.26$150.79M0.3730,205 shs32,196 shsPROFProfound Medical$5.13$5.13$3.90▼$11.42$154.17M0.4463,319 shs43,628 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-9.27%-18.64%-7.98%-60.85%+322,999,900.00%ECORelectroCore+2.03%+1.41%-23.36%-71.59%-28.26%PDEXPro-Dex+2.75%+5.80%-28.11%+42.56%+132.16%PROFProfound Medical0.00%+13.25%+9.85%-31.42%-35.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/AECORelectroCore2.1868 of 5 stars3.53.00.00.00.62.50.6PDEXPro-Dex2.5908 of 5 stars2.52.00.00.03.52.51.9PROFProfound Medical2.5482 of 5 stars3.52.00.00.02.82.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50353.30% UpsideECORelectroCore 3.00Buy$25.50413.08% UpsidePDEXPro-Dex 3.00Buy$52.0012.46% UpsidePROFProfound Medical 3.00Buy$11.50124.17% UpsideCurrent Analyst Ratings BreakdownLatest ECOR, PROF, AVR, and PDEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025PROFProfound MedicalRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Moderate Buy4/23/2025PROFProfound MedicalLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $11.003/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 5/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.71M48.42N/AN/AN/A∞ECORelectroCore$26.46M1.39N/AN/A$1.24 per share4.01PDEXPro-Dex$64.12M2.35$1.33 per share34.81$9.76 per share4.74PROFProfound Medical$11.86M13.00N/AN/A$1.28 per share4.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/AECORelectroCore-$18.83M-$1.56N/AN/AN/A-54.40%-154.45%-69.16%8/6/2025 (Estimated)PDEXPro-Dex$2.13M$2.8023.0122.45N/A11.06%21.68%12.40%N/APROFProfound Medical-$28.57M-$1.22N/AN/AN/A-349.41%-85.22%-64.87%N/ALatest ECOR, PROF, AVR, and PDEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/8/2025Q1 2025PROFProfound Medical-$0.29-$0.36-$0.07-$0.36$4.78 million$2.62 million5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million5/1/2025Q3 2025PDEXPro-Dex$0.47$0.98+$0.51$0.98$17.70 million$17.41 million3/6/2025Q4 2024PROFProfound Medical-$0.31-$0.20+$0.11-$0.20$5.92 million$4.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/APROFProfound MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/AN/AN/AECORelectroCoreN/A2.121.87PDEXPro-Dex0.332.581.44PROFProfound Medical0.116.125.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/AECORelectroCore26.74%PDEXPro-Dex15.28%PROFProfound Medical47.86%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/AECORelectroCore19.70%PDEXPro-Dex47.50%PROFProfound Medical1.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/AECORelectroCore507.42 million5.35 millionNot OptionablePDEXPro-Dex1403.26 million1.71 millionNot OptionablePROFProfound Medical15030.05 million29.58 millionOptionableECOR, PROF, AVR, and PDEX HeadlinesRecent News About These Companies1 Magnificent Healthcare Stock Down 80% to Buy and Hold ForeverMay 22 at 11:19 AM | fool.caProfound Medical Corp. (NASDAQ:PROF) CEO Purchases $43,312.99 in StockMay 21 at 7:11 AM | insidertrades.comStonepine Capital Management LLC Acquires Shares of 200,000 Profound Medical Corp. (NASDAQ:PROF)May 20 at 7:02 AM | marketbeat.comFinancial Review: Meihua International Medical Technologies (NASDAQ:MHUA) and Profound Medical (NASDAQ:PROF)May 20 at 1:47 AM | americanbankingnews.comWhy Profound Medical Corp.’s (PROF) Stock Is Up 5.07%May 16, 2025 | aaii.comProfound Medical Annual General and Special Meeting of Shareholders Voting ResultsMay 14, 2025 | globenewswire.comProfound Medical targets 70%-75% growth in 2025 with new TULSA AI module launchMay 9, 2025 | msn.comProfound Medical Corporation (PROF) Q1 2025 Earnings Conference Call TranscriptMay 9, 2025 | seekingalpha.comAlyeska Investment Group L.P. Buys New Stake in Profound Medical Corp. (NASDAQ:PROF)May 9, 2025 | marketbeat.comProfound Medical Announces First Quarter 2025 Financial ResultsMay 9, 2025 | manilatimes.netProfound Medical (PROF) Reports Q1 Loss, Misses Revenue EstimatesMay 8, 2025 | zacks.comProfound Medical Reports Strong Q1 2025 Growth and Highlights TULSA-PRO AdvancementsMay 8, 2025 | tipranks.com1 Magnificent Canadian Stock Down 52% to Buy and Hold ForeverMay 7, 2025 | msn.comProfound Medical Corp. (NASDAQ:PROF) Shares Bought by Bleichroeder LPMay 7, 2025 | marketbeat.comStrength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?May 5, 2025 | zacks.comAnson Funds Management LP Acquires Shares of 110,000 Profound Medical Corp. (NASDAQ:PROF)May 5, 2025 | marketbeat.com50,000 Shares in Profound Medical Corp. (NASDAQ:PROF) Acquired by AYAL Capital Advisors LtdMay 5, 2025 | marketbeat.comProfound Medical (PROF) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROFMay 1, 2025 | accessnewswire.comProfound Medical: In Serious Trouble Despite Projected GrowthApril 30, 2025 | seekingalpha.comProfound Medical to Present at 2025 Healthcare Investor ConferenceApril 30, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumTempus AI Stock: Time to Double Down or Cut and Run?By Thomas Hughes | May 8, 2025View Tempus AI Stock: Time to Double Down or Cut and Run?Intel Refocuses: NEX Sale and Foundry Pivot Signal New EraBy Jeffrey Neal Johnson | May 21, 2025View Intel Refocuses: NEX Sale and Foundry Pivot Signal New EraMicrosoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsBy Chris Markoch | May 15, 2025View Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsNextracker’s Solar Surge: Will It Shatter Its All-Time High?By Thomas Hughes | May 18, 2025View Nextracker’s Solar Surge: Will It Shatter Its All-Time High?ECOR, PROF, AVR, and PDEX Company DescriptionsAnteris Technologies Global NASDAQ:AVR$3.64 +0.41 (+12.69%) As of 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.electroCore NASDAQ:ECOR$4.97 -0.05 (-1.00%) Closing price 04:00 PM EasternExtended Trading$4.94 -0.02 (-0.50%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Pro-Dex NASDAQ:PDEX$46.24 +0.62 (+1.36%) Closing price 04:00 PM EasternExtended Trading$46.25 +0.01 (+0.02%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Profound Medical NASDAQ:PROF$5.08 -0.04 (-0.88%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
